{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:33:12Z","timestamp":1794479592784,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurobiolaging.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:32:22Z","timestamp":1776814342000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An exploratory analysis of plasma biomarkers associated with cerebral amyloid angiopathy"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-5894","authenticated-orcid":false,"given":"Ersin","family":"Ers\u00f6zl\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Preis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orkan","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Gref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Droste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hellmann-Regen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","article-title":"Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1098-1136(200010)32:1<25::AID-GLIA30>3.0.CO;2-Y","article-title":"Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration","volume":"32","author":"Bechmann","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib3","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1038\/s41598-021-83601-6","article-title":"Plasma osteopontin as a biomarker of Alzheimer\u2019s disease and vascular cognitive impairment","volume":"11","author":"Chai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2003.08.007","article-title":"Fas ligand\/Fas system in the brain: regulator of immune and apoptotic responses","volume":"44","author":"Choi","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120866","article-title":"Exploring cerebral amyloid angiopathy: insights into pathogenesis, diagnosis, and treatment","volume":"454","author":"Cozza","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib7","doi-asserted-by":"crossref","unstructured":"Cummings, J., Gold, M., Mintun, M., Irizarry, M., von Eschenbach, A., Hendrix, S., Berry, D., Sampaio, C., Sink, K., Landen, J., Kivipelto, M., Grundman, M., Arnold, S.E., Green, A., Partrick, K., Nisenbaum, L., Burstein, A., Fillit, H., n.d. Key Considerations for Combination Therapy in Alzheimer\u2019s Clinical Trials: Perspectives from an Expert Advisory Board Convened by the Alzheimer\u2019s Drug Discovery Foundation. \u3008https:\/\/doi.org\/10.1016\/j.tjpad.2024.100001\u3009.","DOI":"10.1016\/j.tjpad.2024.100001"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-019-0662-1","article-title":"Apolipoprotein E and clusterin inhibit the early phase of amyloid-\u03b2 aggregation in an in vitro model of cerebral amyloid angiopathy","volume":"7","author":"Endo","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer\u2019s disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bpa.12721","article-title":"Osteopontin and phospho-SMAD2\/3 are associated with calcification of vessels in D-CAA, an hereditary cerebral amyloid angiopathy","volume":"29","author":"Grand Moursel","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib12","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","article-title":"Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques","volume":"22","author":"Huang","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.56.4.537","article-title":"Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria","volume":"56","author":"Knudsen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00401-024-02767-1","article-title":"Differences in the cerebral amyloid angiopathy proteome in Alzheimer\u2019s disease and mild cognitive impairment","volume":"148","author":"Leitner","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib18","first-page":"19","article-title":"Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue","volume":"3","author":"Love","year":"2014","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0969-9961(02)00019-0","article-title":"Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in \u03b2-amyloid-induced neuronal death","volume":"12","author":"Su","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209386","article-title":"Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathologic validation study","volume":"102","author":"Switzer","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib22","article-title":"Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review","volume":"2","author":"Theodorou","year":"2021","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000441919","article-title":"Cerebral \u03b2-amyloid angiopathy is associated with earlier dementia onset in Alzheimer\u2019s disease","volume":"16","author":"Vidoni","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2026.04.004_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat. Immunol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:05:33Z","timestamp":1794477933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0197458026000618"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An exploratory analysis of plasma biomarkers associated with cerebral amyloid angiopathy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}